Koji Nanmoku Akira Kurosawa Takahiro Shinzato Toshihiro Shimizu Takaaki Kimura Takashi Yagisawa
10.2169/internalmedicine.56.8142
Intern Med
2017;56(11):1387-1391.
2,8-dihydroxyadenine nephropathy adenine phosphoribosyltransferase deficiency febuxostat kidney transplantation nephrolithiasis xanthine dehydrogenase inhibitor
CC BY-NC-ND
https://pubmed.ncbi.nlm.nih.gov/28566603/
Adenine Phosphoribosyltransferase / deficiency Febuxostat / administration & dosage Gout Suppressants / administration & dosage Kidney Transplantation / methods Metabolism, Inborn Errors / prevention & control Urolithiasis / prevention & control
Adenine Phosphoribosyltransferase / deficiency Febuxostat / administration & dosage Gout Suppressants / administration & dosage Kidney Transplantation / methods Metabolism, Inborn Errors / prevention & control Urolithiasis / prevention & control Case Reports Adenine / analogs & derivatives Adenine / metabolism Adult Humans Male Gout Suppressants Febuxostat 2,8-dihydroxyadenine Adenine Phosphoribosyltransferase Adenine Adenine phosphoribosyltransferase deficiency
PMC5498204
28566603
Febuxostat for the Prevention of Recurrent 2,8-dihydroxyadenine Nephropathy due to Adenine Phosphoribosyltransferase Deficiency Following Kidney Transplantation
2017